Moderna’s combined Covid-19 and flu vaccine outperforms separate shots in Phase 3 trials.
Moderna, the pharmaceutical giant, has reported that its combined vaccine for Covid-19 and influenza produced a stronger immune response in adults aged 50 and older compared to separate shots for each virus in a Phase
Read More
